序号 |
标题 |
次数 |
作者 |
发布时间 |
83701 |
环糊精类金属有机框架负载姜黄素 CurCDMOFs |
200 |
h |
2024-11-28 |
83702 |
DOTA-PEG(2)-DTyr-Gln-Trp-Ala-Val-bAla-His-Phe-Nle-NH2 ,DOTA肽缀合物 |
116 |
kx |
2024-11-28 |
83703 |
DOTA-(Tyr3)-Octreotate acetate salt |
102 |
zyl |
2024-11-28 |
83704 |
四嗪类高氮含能化合物3,6-双(1H-1,2,3,4-四唑-5-氨基)-s-四嗪 |
109 |
WYQ |
2024-11-28 |
83705 |
DOTA-TCTP-1 , DOTA偶联TCTP-1多肽 |
129 |
kx |
2024-11-28 |
83706 |
1-[6-(3,5-二甲基-1H-吡唑-1-基)-1,2,4,5-四嗪-3-基]酰肼 |
102 |
WYQ |
2024-11-28 |
83707 |
3-胍基-6(3,5-二甲基吡唑)-1,2,4,5-四嗪高氯酸盐甲醇合物(BGTz·HClO4·CH3OH) |
99 |
WYQ |
2024-11-28 |
83708 |
钬-DOTA复合物 , Holmium-DOTA |
178 |
kx |
2024-11-28 |
83709 |
DOTA-tris(TBE)-amido dPEG-MAL |
119 |
zyl |
2024-11-28 |
83710 |
DOTA-monoamide ;DOTA-单酰胺复合物 |
108 |
wyh |
2024-11-28 |
83711 |
DOTA-PEG(23)-bromoacetamide*2TFA |
158 |
zyl |
2024-11-28 |
83712 |
DOTA-BASS;DOTA偶联sst拮抗剂 |
106 |
wyh |
2024-11-28 |
83713 |
DOTA-赖氨酸 , DOTA-lysine |
93 |
kx |
2024-11-28 |
83714 |
DOTA(tBu3)-PEG(4)-TFP |
222 |
zyl |
2024-11-28 |
83715 |
DOTA-phenylalanine;DOTA-苯丙氨酸 |
87 |
wyh |
2024-11-28 |
83716 |
NOTA-抗CTLA-4单克隆抗体 , DOTA-抗CTLA-4mAb |
120 |
kx |
2024-11-28 |
83717 |
金属螯合剂DOTA偶联α-MSH类似物 |
123 |
wyh |
2024-11-28 |
83718 |
Gd-DOTA-c(RGD-ACH-K), 氨基环己烷偶联Gd-DOTA(钆-四氮杂环十二烷四乙酸)和环状RGDK肽 |
97 |
kx |
2024-11-28 |
83719 |
DOTA-MBA;1,4,7,10-四氮杂-4,7,10-三甲基-环十二烷基-R-(+)-α-甲基苄胺 |
94 |
wyh |
2024-11-28 |
83720 |
DOTA-唑来膦酸结合物 , DOTA-zoledronate conjugate |
95 |
kx |
2024-11-28 |
83721 |
β环糊精聚乙烯亚胺修饰碳量子点 PEI-β-CyD/CDs |
144 |
h |
2024-11-28 |
83722 |
DOTA−Lysine−Biotin ;DOTA -赖氨酸-生物素 |
99 |
wyh |
2024-11-28 |
83723 |
氮掺杂碳量子点/银纳米粒子/β-环糊精复合材料 N-CQDs/AgNPs/β-CD |
132 |
h |
2024-11-28 |
83724 |
DOTA缀合(+)-生物素二聚体, DOTA conjugated (+)-biotin |
85 |
kx |
2024-11-28 |
83725 |
DOTA-8-Aoc-BBN[7–14]NH |
113 |
wyh |
2024-11-28 |
83726 |
DOTA-MSOct的性质 |
96 |
wyh |
2024-11-28 |
83727 |
β-环糊精官能化的氮掺杂石墨烯量子点 βCDNGQDs |
109 |
h |
2024-11-28 |
83728 |
DOTA-PSMA-EB-01 |
133 |
zyl |
2024-11-28 |
83729 |
DOTA-capsaicin, DOTA-辣椒碱 |
105 |
kx |
2024-11-28 |
83730 |
CAS:1800229-46-2 Maleimide-DOTA-GA |
103 |
zyl |
2024-11-28 |
83731 |
β-环糊精修饰碳量子点 β-CD-CQDs |
136 |
h |
2024-11-28 |
83732 |
DOTA-IAC的组成和结构、功能与应用 |
142 |
kx |
2024-11-28 |
83733 |
环糊精纳米海绵-石墨烯量子点-多壁碳管复合物 CDNS/GQDs/MWCNTs-COOH |
142 |
h |
2024-11-28 |
83734 |
DOTA-三(酸) - 酰氨基-DPEG(R)11-马来酰亚胺 |
98 |
zyl |
2024-11-28 |
83735 |
DOTA-2IT-m170 ;金属螯合物DOTA偶联单克隆抗体m170 |
101 |
wyh |
2024-11-28 |
83736 |
β-环糊精修饰Mn-ZnS量子点 β-CD@Mn-ZnS QDs |
105 |
h |
2024-11-28 |
83737 |
DOTA-抗ROBO1单克隆抗体 ; 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)缀合抗ROBO1单克隆抗体 |
136 |
kx |
2024-11-28 |
83738 |
水溶性β-环糊精修饰的金量子点 β-CD-Au QDs |
103 |
h |
2024-11-28 |
83739 |
DOTA-Suc-Lys-(FAPI-04)2 3029114-60-8 DOTA-琥珀酰基-赖氨酸-(FAPI-04)2 |
102 |
zyl |
2024-11-28 |
83740 |
明胶/高良姜精油/β-环糊精复合纳米纤维膜 SG/GRO/β-CD-IC |
119 |
h |
2024-11-28 |
83741 |
Gd-DOTA-SPD复合物的组成成分 |
109 |
wyh |
2024-11-28 |
83742 |
DOTA-TBIA101 ,DOTA结合的微生物肽衍生物 |
113 |
kx |
2024-11-28 |
83743 |
四嗪类高氮含能化合物3,6-双(1H-1,2,3,4-四唑-5-氨基)-s-四嗪 |
95 |
WYQ |
2024-11-28 |
83744 |
1,4,7,10-四(羧甲基)-1,4,7,10-四氮杂环十二烷单酰胺偶联乳糖 |
97 |
wyh |
2024-11-28 |
83745 |
CAS: 834870-39-2 DOTA series |
96 |
zyl |
2024-11-28 |